RELX/£REL
1D1W1MYTD1Y5YMAX
Capital at risk
About RELX
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
- Ticker
- £REL
- Sector
- Business services
- Primary listing
- LSE
- Employees
- 37,000
- Headquarters
- London, United Kingdom
- Website
- www.relx.com
RELX Metrics
BasicAdvanced
£43B
19.71
£1.25
0.26
£0.69
2.80%
Price and volume
Market cap
£43B
Beta
0.26
52-week high
£35.69
52-week low
£19.91
Average daily volume
4.2M
Dividend rate
£0.69
Financial strength
Current ratio
0.449
Quick ratio
0.394
Long term debt to equity
5.229
Total debt to equity
7.096
Dividend payout ratio (TTM)
53.40%
Interest coverage (TTM)
18.91%
Profitability
EBITDA (TTM)
3,292
Gross margin (TTM)
66.42%
Net profit margin (TTM)
23.27%
Operating margin (TTM)
31.71%
Effective tax rate (TTM)
23.95%
Revenue per employee (TTM)
£260,000
Management effectiveness
Return on assets (TTM)
13.12%
Return on equity (TTM)
131.86%
Valuation
Price to earnings (TTM)
19.707
Price to revenue (TTM)
4.567
Price to book
34.63
Price to tangible book (TTM)
-4.3
Price to free cash flow (TTM)
19.141
Free cash flow yield (TTM)
5.22%
Free cash flow per share (TTM)
1.285
Dividend yield (TTM)
2.80%
Growth
Revenue change (TTM)
1.95%
Earnings per share change (TTM)
20.69%
3-year revenue growth (CAGR)
2.29%
10-year revenue growth (CAGR)
4.49%
3-year earnings per share growth (CAGR)
11.01%
10-year earnings per share growth (CAGR)
9.06%
3-year dividend per share growth (CAGR)
7.22%
10-year dividend per share growth (CAGR)
7.79%
What the Analysts think about RELX
Analyst ratings (Buy, Hold, Sell) for RELX stock.
Analyst projections of the future price of RELX stock.
Bulls say / Bears say
RELX delivered strong first-half 2026 momentum, with revenue up 7% organically, adjusted operating profit up 9%, adjusted EPS up 11% in constant currency and margin expanding to 35.5%; management reaffirmed the full-year outlook. (RELX)
The shift toward higher-growth analytics and decision tools remains company-specific and structural: Risk, Legal, Scientific, Technical & Medical and Exhibitions all reported positive momentum, supported by proprietary content, data and AI-enabled workflows. (RELX)
Shareholder returns are well supported by cash generation: adjusted cash-flow conversion was 98%, the interim dividend increased 7%, and £1.75 billion of the previously announced £2.25 billion buyback had been completed by June 30, 2026. (RELX)
Leverage increased: net debt/EBITDA rose to 2.3x at June 30, 2026 from 2.2x a year earlier, while net debt reached £8.733 billion; continued acquisitions and buybacks could constrain financial flexibility. (RELX)
RELX remains exposed to regulatory, privacy, intellectual-property, cybersecurity and data-use risks across its risk, legal and scientific businesses; adverse changes could increase compliance costs or restrict product functionality. (RELX)
Generative AI creates execution and reputational risks: inaccurate or fabricated outputs, fraudulent research submissions and intensifying competition could weaken customer trust or pressure the value of traditional information products. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 14 Sept 2026.
RELX Financial Performance
Revenues and expenses
RELX Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing RELX
AllEURGBPUSD
Fund name | Fund size | £REL weighting |
|---|---|---|
iShares STOXX Europe 600 Technology€STEC | €26M | 6.65% |
iShares STOXX Europe 600 Technology€EXV3 | €224M | 6.65% |
iShares MSCI Europe Industrials Sector€ESIN | €1.3B | 2.00% |
iShares MSCI Europe Industrials Sector£ESIN | £1.1B | 2.00% |
Vanguard FTSE 100£VUKE | £4.8B | 1.82% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.